Leadership Overview
Shilpa Medicare has 4 executives leading key functions including financial strategy, operational oversight, biopharma innovation, and North American business development.
Focused on global pharmaceutical excellence, Shilpa Medicare delivers advanced oncology solutions and specialized drug delivery systems to international markets while maintaining a commitment to high-quality manufacturing standards.
Focused on global pharmaceutical excellence, Shilpa Medicare delivers advanced oncology solutions and specialized drug delivery systems to international markets while maintaining a commitment to high-quality manufacturing standards.
Leadership Roles at Shilpa Medicare
Alpesh Dalal - Chief Financial Officer
Alpesh Dalal, the Chief Financial Officer at Shilpa Medicare, manages the entire fiscal architecture of the organization. Overseeing capital allocation and financial reporting, the Chief Financial Officer ensures the stability of investments in active pharmaceutical ingredients and oncology research. This leadership role involves rigorous oversight of international revenue streams across India, the United States, and Europe. By optimizing cost structures and managing liquidity, Alpesh Dalal directly impacts the long-term growth trajectory of the company. The Chief Financial Officer also coordinates with the Board to align fiscal policies with the broader corporate mission of expanding drug delivery systems. Through precise financial planning, Dalal secures the necessary resources for manufacturing expansion and wind power generation initiatives. Ultimately, the Chief Financial Officer maintains the fiscal health required to support complex pharmaceutical development cycles and global market penetration.
Vellaian Karuppiah - Chief Operating Officer
Vellaian Karuppiah, the Chief Operating Officer at Shilpa Medicare, directs the manufacturing and supply chain operations for all pharmaceutical products. Overseeing the production of tablets, capsules, and sterile injectables, the Chief Operating Officer ensures strict adherence to global quality standards. This leadership role involves managing the operational efficiency of facilities producing oncology and non-oncology API's. By streamlining production workflows, Vellaian Karuppiah directly impacts the company's ability to meet international demand for specialized drug delivery systems. The Chief Operating Officer also monitors the performance of wind power generation assets to ensure sustainable energy integration within the manufacturing process. Through constant process improvement, Karuppiah drives operational excellence across all dosage form production lines. Ultimately, the Chief Operating Officer maintains the high-volume output necessary to sustain the company's competitive position in the global pharmaceutical market.
Harshawardhan Bal - President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing)
Harshawardhan Bal, the President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing) at Shilpa Medicare, architects the strategic integration of artificial intelligence and machine learning into drug discovery. Overseeing the development of peptides and biotech products, the President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing) ensures the company remains at the forefront of pharmaceutical innovation. This leadership role involves securing high-value partnerships and licensing agreements that expand the reach of proprietary drug delivery systems. By leveraging advanced computational tools, Harshawardhan Bal directly impacts the speed and accuracy of the biopharma manufacturing pipeline. The President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing) also collaborates with global research teams to identify new therapeutic targets. Through these technological advancements, Bal accelerates the commercialization of complex biotech solutions. Ultimately, the President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing) secures the company's future as a leader in high-tech pharmaceutical development.
Harsh Bal - President, Cdmo Business (North America )
Harsh Bal, the President, Cdmo Business (North America ) at Shilpa Medicare, drives the expansion of contract manufacturing services across the North American market. Overseeing client relationships and service delivery for sterile injectables and specialty chemicals, the President, Cdmo Business (North America ) ensures alignment with regional regulatory requirements. This leadership role involves scaling the company's presence to meet the specific needs of North American pharmaceutical partners. By managing complex supply chains and service contracts, Harsh Bal directly impacts the revenue growth generated from international CDMO operations. The President, Cdmo Business (North America ) also coordinates with internal manufacturing teams to ensure that production capabilities match the high demand for oncology and non-oncology formulations. Through strategic market engagement, Bal strengthens the company's reputation as a reliable manufacturing partner. Ultimately, the President, Cdmo Business (North America ) secures long-term commercial success by expanding the footprint of the company's specialized dosage form services.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership LT
PL
RH
Biogen is a U.S.-based biotechnology company focused on discovering, developing, and commercializing therapies for serious neurological and neurodegenerative diseases. Its core portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and other rare neurological disorders, supported by advanced research in neuroscience, biologics, and gene-based therapies.
Company Leadership
ER
WC
Eli Lilly and Company is a global biopharmaceutical firm engaged in the discovery, development, manufacturing, and commercialization of prescription medicines. It focuses on areas such as diabetes, oncology, immunology, and neuroscience, serving patients across international markets through research-driven innovation.
Company Leadership
OrchidPharma Ltd is a vertically integrated pharmaceutical company with established research, manufacturing, and marketing capabilities across multiple therapeutic domains in healthcare. The company aims to build a sustainable organizational ecosystem that motivates individuals to achieve new heights and discover growth avenues. OrchidPharma is driven by values such as innovation and corporate social responsibility, alongside its strategic goals. Its intended clients include healthcare providers and organizations seeking comprehensive pharmaceutical solutions.
Company Leadership
MS
PP
NA
Frequently Asked Questions Regarding Shilpa Medicare Top Executives and Leadership Team
